Synthesis and evaluation of novel oxazoline MMP inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 19, 2004, Pages 4935-4939

  Cook, Gregory R ^a   Manivannan, Ethirajan ^a   Underdahl, Thane ^b   Lukacova, Viera ^b   Zhang, Yufen ^b   Balaz, Stefan ^b  

^a Center for Protease Research   (United States)

^b DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Heterocycles; MMP inhibitors; Oxazolines; Zinc binding

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE INHIBITOR; OXAZOLINE DERIVATIVE; ZINC;

ARTICLE; DRUG BINDING; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; METAL BINDING; PROTEINASE INHIBITION;

MATRIX METALLOPROTEINASES; OXAZOLES; PROTEASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 4444357246     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.07.023     Document Type: Article

References (37)

1. C.M. Overall, and C. López-Otín Nature Rev. Cancer 2 2002 657 672
2. J.B. Summers, and S.K. Davidsen Ann. Reps. Med. Chem. 33 1998 131 140
3. W.K. Hagmann, M.W. Lark, and J.W. Becker Ann. Reps. Med. Chem. 31 1996 140 231
4. M. Whittaker, C.D. Floyd, P. Brown, and A.J.H. Gearing Chem. Rev. 99 1999 2735 2776
5. L.L. Johnson, R. Dyer, and D.J. Hupe Current Opinion Chem. Biol. 2 1998 266 471
6. H. Nagase Biol. Chem 378 1997 151 180
7. (g) Himelstein, B. P.; Canete-Soler, R.; Bernhard, E. J.; Dilks, D. W.; Muschel, R. J. Invas. Metast. 1994-95, 14, 246-258
8. (h) Polette, M.; Birembaut, P. Int. J. Biochem-Cell-Biol. 1998, 30, 1195-1202
9. S.M. Ellerbroek, and M.S. Stack Bioessay 21 1999 940 949
10. D.E. Kleiner, and W.G. Stetler-Stevenson Cancer Chemother. Pharmacol. 43 Suppl. S 1999 S42 S51
11. L.M. Coussens, and Z. Werb Chem. Biol. 3 1996 895 904
12. S.A. Watson, and G. Tierney Biodrugs 9 1998 325 335
13. D.E. Levy, F. Lapierre, W. Liang, W. Ye, C.W. Lange, X. Li, D. Grobelny, M. Casabonne, D. Tyrrell, K. Holme, A. Nadzan, and R.E. Galardy J. Med. Chem. 41 1998 199 223
14. S. Chandler, K.M. Miller, J.M. Clements, J. Lury, D. Corkill, D.C.C. Anthony, S.E. Adams, and A.J.H. Gearing J. Neuroimmunol. 72 1997 155 161
15. J.R. Morphy, T.A. Millican, and J.R. Porter Curr. Med. Chem. 2 1995 743 762
16. S. Hanessian, S. Bouzbouz, A. Boudon, G.C. Tucker, and D. Peyroulan Biorg. Med. Chem. Lett. 9 1999 1691 1696
17. V.-J. Uitto, C.M. Overall, and C. McCulloch Periodontology 2000 31 2003 77 104
18. M.D. Sternlicht, and Z. Werb Ann. Rev. Cell Dev. Biol. 17 2001 463 516
19. M.D. Sternlicht, L.M. Coussens, T.H. Vu, and Z. Werb Matrix Metalloproteinase Inhibitors Cancer Therapy 2001 1 37
20. M.D. Sternlicht, and G. Bergers Emerging Therapeutic Targets 4 2000 609 633
21. M.D. Sternlicht, A. Lochter, C.J. Sympson, B. Huey, J.-P. Rougier, J.W. Gray, D. Pinkel, M.J. Bissell, and Z. Werb Cell 98 1999 137 146
22. M.D. Sternlicht, M.J. Bissell, and Z. Werb Oncogene 19 2000 1102 1113
23. For an excellent example of a simple sulfonamide carboxylate bound to the zinc and S1′ pocket, see: A.G. Pavlovsky, M.G. Williams, Q.-Z. Ye, D.F. Ortwine, C.F. Purchase II, A.D. White, V. Dhanaraj, B.D. Roth, L.L. Johnson, D. Hupe, C. Humblet, and T.L. Blundell Protein Sci. 8 1999 1455
24. For recent studies of other potential MMPI ZBG's with model zinc complexes, see: D.T. Puerta, J.A. Lewis, and S.M. Cohen J. Am. Chem. Soc. 126 2004 8388 8389
25. R.E. Babine, and S.L. Bender Chem. Rev. 97 1997 1359 1472
26. Z. Wu, and C. Walsh J. Am. Chem. Soc. 118 1996 1785 1786
27. P.D. Brown APMIS 107 1999 174 180
28. L.M. Coussens, B. Fingleton, and L.M. Matrisian Science 295 2002 2387 2392
29. S.R. Bramhall, M.T. Hallissey, J. Whiting, J. Scholefield, G. Tierney, R.C. Stuart, R.E. Hawkins, P. McCulloch, T. Maughan, P.D. Brown, M. Baillet, and J.W.L. Fielding Br. J. Cancer 2002 1864 1870
30. S.R. Bramhall, A. Rosemurgy, P.D. Brown, C. Bowry, J.A.C. Buckels, L. Lambiase, A. Langleben, M. Shparber, J. Clark, P. Kaywin, J. Lutzsky, P. Benedetto, P. Boasberg, H. Harris, G. Leichman, D. Casciato, J. Harris, S. Mani, D. Van Echo, S. Dutta, B. Culliney, S. Zaknoen, A. Cohn, P. Byrne, D. Waterhouse, D. Brookes, H. Garewel, A. Staddon, B. Cynwyd, L. Einhorn, R. Winston, I. Berkowitz, A. Keller, G. Goldsmith, C. Imrie, C. Johnson, F. Daniel, H. Scarffe, M. Spittle, R. Charnley, H. Barr, D. Lloyd, W. Steward, J. Neoptolemos, S. Falk, T. Wheeler, D. Cunningham, P. Guillou, S. Van Belle, J. Moreau, M. Delgado, R. Houston, S. Rosewicz, P. Malfertheiner, and M. Buchler J. Clin. Oncol. 19 2001 3447 3455
31. M.D. Groves, V.K. Puduvalli, K.R. Hess, K.A. Jaeckle, P. Peterson, W.K.A. Young, and V.A. Levin J. Clin. Oncol. 20 2002 1383 1388
32. G.R. Cook, and K. Pararajasingham Tetrahedron Lett. 43 2002 9027 9029
33. G.R. Cook, and P.S. Shanker J. Org. Chem. 66 2001 6818
34. G.R. Cook, P.S. Shanker, and S.L. Peterson Org. Lett. 1 1999 615
35. V. Dhanaraj, M.G. Williams, Z.-Z. Ye, F. Molina, L.L. Johnson, D.F. Ortwine, A. Pavlovsky, J.R. Rubin, R.W. Skeean, A.D. White, C. Humblet, D.J. Hupe, and T.L. Blundell Croatica Chim. Acta 72 1999 575
36. These four were chosen to represent the majority of the MMPs. For a discussion of the similarity of MMP binding sites, see: V. Lukacova, Y. Zhang, M. Mackov, P. Baricic, S. Raha, J.A. Calvo, and S. Balaz J. Biol. Chem. 2004 279
37. H.M. Muller-Steffner, O. Malver, L. Hosie, N.J. Oppenheimer, and F. Schuber J. Biol. Chem. 267 1992 9606